R&D channel feed – Endpoints News

R&D channel feed

Regeneron, Sanofi post good PhIII asthma data for Dupixent — but it’s losing its halo

8 years ago

#ESMO17 roundup: Idera shares spike on early TLR9 combo data; Erytech touts pancreatic cancer PhIIb data

8 years ago

#ESMO17: Roche extends losing streak with a setback for Zelboraf as Novartis combo surges ahead

8 years ago

J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market

8 years ago

#ESMO17: Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer

8 years ago

#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage

8 years ago

#ESMO17: AstraZeneca salves stinging setback with a big win in a blockbuster segment of the lung cancer market

8 years ago

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

8 years ago

#ESMO17 ROUNDUP: Merck’s data on Keytruda/chemo combo for lung cancer takes early spotlight at ESMO

8 years ago

Hammered by critics, NewLink strikes back with positive PhII indoximod data — and shares rocket up

8 years ago

Eli Lilly slashes R&D jobs, shutters 2 research sites as it looks to cut 3,500 staffers worldwide

8 years ago

AbbVie adds more stellar data on ABT-494 — this time for atopic dermatitis

8 years ago

AstraZeneca, Amgen whip up some blockbuster excitement with a possible game-changing asthma drug

8 years ago

Sarepta readies FDA pitch after a small study spotlights 1% dystrophin add for golodirsen in Duchenne MD

8 years ago

Voyager Therapeutics adds proof its gene therapy for Parkinson's can work, shares soar

8 years ago

Verastem's low-stakes comeback gamble on an AbbVie/Infinity castoff pays off with positive CLL data

8 years ago

Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch

8 years ago

In staggering setback, toxic reaction kills Cellectis’ first CAR-T patient, forcing trial halt

8 years ago

Takeda partners with Noile-Immune on next-gen CAR-T pipeline for solid tumors

8 years ago

Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug

8 years ago

Incyte's good week continues with an encouraging update on IDO1 star epacadostat

8 years ago

Otonomy staggered by an ugly PhIII failure for lead pipeline drug

8 years ago

Medicines Co scores FDA OK for new antibiotic, now up on the auction block

8 years ago

Merck hits a bloop single in an epic PhIII CETP cardio contest. Now what?

8 years ago

First page Previous page 289 290 291292293 294 295 Next page Last page